Search - tctmd.com

Displaying 301 - 320 of 338

Sort: Relevancy | Date

News Daily News

Patients With A-fib Still Have High Mortality Risk After Appropriate Anticoagulation Is Started

December 05, 2016

News Daily News

Tricky Population of Patients With A-fib Undergoing PCI Tackled in New Consensus Document

November 29, 2016

News Conference News AHA 2016

Errar la Dosis de NOAC en la Práctica Clínica Diaria es algo Habitual, lo cual tiene Implicaciones en Materia de ACV y Hemorragias

November 21, 2016

News Conference News AHA 2016

Subclinical A-fib Common in Older, Asymptomatic Patients

November 18, 2016

News Conference News AHA 2016

La FA Subclínica es Común en Pacientes Asintomáticos de Mayor Edad

November 18, 2016

News Conference News AHA 2016

Rivaroxaban-Based Double or Triple Therapy Cuts Bleeding in Patients With A-fib Undergoing PCI: PIONEER AF-PCI

November 14, 2016

News Daily News

New-Onset Atrial Fibrillation Post-CABG More Common, Lasts Longer in Men Than in Women

October 19, 2016

News Daily News

Short Bouts of Atrial Tachyarrhythmia Do Not Worsen Prognosis, Study Suggests

October 19, 2016

News Daily News

FDA: ROCKET AF Results Not Affected by Faulty INR Testing in Warfarin Arm

Michael O'Riordan

October 11, 2016

News Daily News

Addition of Biomarkers May Fine Tune Risk Stratification in Atrial Fibrillation

Michael O'Riordan

October 07, 2016

News Daily News

Were Problems With the Point-of-Care Device Used in ROCKET AF Kept From the FDA? BMJ Says Yes

September 28, 2016

News Daily News

Low-Dose NOACs Top Warfarin in Asian Patients in Everyday Practice, Retrospective Study Suggests

September 26, 2016

News Daily News

Las Dosis Bajas de Superan a la Warfarina en Pacientes Asiáticos en la Práctica Rutinaria, según un Estudio Retrospectivo

September 26, 2016

News Daily News

Stroke Not the Only Concern in Patients With A-fib

September 07, 2016

News Conference News ESC 2016

Reversal Agent for Factor Xa Inhibitors Rapidly Reduces Anticoagulant Effects: ANNEXA-4

August 31, 2016

News Conference News ESC 2016

NOACs as Effective as Warfarin for Reducing Stroke, but Apixaban and Dabigatran May Carry Lower Bleeding Risk: Registry

Michael O'Riordan

August 28, 2016

News Daily News

Increased Risk of In-Hospital Complications, Including Mortality, Among A-fib Patients Undergoing PCI

Michael O'Riordan

August 24, 2016

News Daily News

Drug Company Payments to Physicians May Be Influencing Prescribing

August 23, 2016

News Daily News

FDA Declines to Approve Portola’s Reversal Agent for Factor Xa Inhibitors

Michael O'Riordan

August 18, 2016

News Daily News

Data Gap: Best Strategy Unknown for A-Fib Patients on Newer Anticoagulants Who Need PCI

August 17, 2016

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.